Not Medicare Enrolled

Dr. Gregory Friess, D.O.

Hematology & Oncology · Fort Worth, TX
Low-engagement
800 W MAGNOLIA AVE, Fort Worth, TX 76104
8177597000
In practice since 2006 (19 years)
NPI: 1952351736 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Friess from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Friess? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Friess

Dr. Gregory Friess is a hematology & oncology specialist in Fort Worth, TX, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Friess received a total of $1,574 from 26 pharmaceutical and/or device companies across 76 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Friess is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice $1,574 industry payments

Industry Payment Transparency

Open Payments through 2020 ↗
$1,574
Total received (2018-2020)
Avg $525/year across 3 years
Bottom 36% in TX for hematology & oncology
26
Companies
76
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,417 (90.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$157 (10.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2020
$84
2019
$893
2018
$597

Payments by company (2020)

Consulting
Speaking
Meals & Travel
Research
Genentech USA, Inc.
$186
Lilly USA, LLC
$135
Merck Sharp & Dohme Corporation
$130
Amgen Inc.
$124
E.R. Squibb & Sons, L.L.C.
$93
Novartis Pharmaceuticals Corporation
$85
Bayer HealthCare Pharmaceuticals Inc.
$84
Teva Pharmaceuticals USA, Inc.
$79
Takeda Pharmaceuticals U.S.A., Inc.
$75
Verastem, Inc.
$74
TerSera Therapeutics LLC
$55
Boehringer Ingelheim Pharmaceuticals, Inc.
$47
Puma Biotechnology, Inc.
$46
Ipsen Biopharmaceuticals, Inc
$45
Seattle Genetics, Inc.
$42
Exelixis Inc.
$38
Gilead Sciences, Inc.
$37
AstraZeneca Pharmaceuticals LP
$36
Janssen Biotech, Inc.
$35
Taiho Oncology, Inc.
$24
Array BioPharma Inc.
$24
Heron Therapeutics, Inc.
$18
Celgene Corporation
$17
Pharmacyclics LLC, An AbbVie Company
$17
GENZYME CORPORATION
$14
TESARO, Inc.
$14
Top 3 companies account for 28.6% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · ALIMTA · Aliqopa · Avastin · Braftovi · Cabometyx · Copiktra · ERBITUX · Erleada · GAZYVA · GILOTRIF · IMFINZI · Imbruvica · JADENU · JEVTANA · KEYTRUDA · Kyprolis · LENVIMA · Lonsurf · Nerlynx · Neulasta · Nplate · OPDIVO · PROMACTA · Perjeta · Revlimid · SOMATULINE DEPOT · SPRYCEL · SUSTOL · Stivarga · VARUBI · VERZENIO · Xofigo · ZEJULA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (90%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a hematology & oncology specialist in Fort Worth?
Compare hematology & oncology specialists in the Fort Worth area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
47
Per 100K population
2.2
County median income
$81,905
Nearest hospital
JPS HEALTH NETWORK
0.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2020
Disciplinary History — Not public N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Friess is a hematology & oncology specialist, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Friess receive payments from pharmaceutical companies?
Yes. Dr. Friess received a total of $1,574 from 26 companies across 76 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Friess) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Hematology & Oncology Specialists in Fort Worth
Browse hematology & oncology specialists in Fort Worth ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in TX
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in TX
Which TX hematology & oncology specialists receive the most from drug and device companies.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Merck Sharp & Dohme Corporation Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme Corporation.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →